The DOI matches its Crossref record; 428 of the 428 references it cites were found in a registry or an index.
Molecular genetics of prostate cancer: new prospects for old challenges
Open accessAbstract
Despite much recent progress, prostate cancer continues to represent a major cause of cancer-related mortality and morbidity in men. Since early studies on the role of the androgen receptor that led to the advent of androgen deprivation therapy in the 1940s, there has long been intensive interest in the basic mechanisms underlying prostate cancer initiation and progression, as well as the potential to target these processes for therapeutic intervention. Here, we present an overview of major themes in prostate cancer research, focusing on current knowledge of principal events in cancer initiation and progression. We discuss recent advances, including new insights into the mechanisms of castration resistance, identification of stem cells and tumor-initiating cells, and development of mouse models for preclinical evaluation of novel therapuetics. Overall, we highlight the tremendous research progress made in recent years, and underscore the challenges that lie ahead.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 428
Basal epithelial stem cells are efficient targets for prostate cancer initiation
Lawson, D. A., Zong, Y., Memarzadeh, S., Xin, L., Huang, J., & Witte, O. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913873107 · Cited by 275
Gregory, C. W., Hamil, K. G., Kim, D., Hall, S. H., Pretlow, T. G., Mohler, J. L., & French, F. S. (1998) · PubMed · Cited by 275
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate
Clark, J., Merson, S., Jhavar, S., Flohr, P., Edwards, S., Foster, C. S., Eeles, R., Martin, F. L., Phillips, D. H., Crundwell, M., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210070 · Cited by 271
Bostwick, D. G., Alexander, E. E., Singh, R., Shan, A., Qian, J., Santella, R. M., Oberley, L. W., Yan, T., Zhong, W., Jiang, X., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000701)89:1<123::aid-cncr17>3.0.co;2-9 · Cited by 269
Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
Lapointe, J., Li, C., Giacomini, C. P., Salari, K., Huang, S., Wang, P., Ferrari, M., Hernandez-Boussard, T., Brooks, J. D., & Pollack, J. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0673 · Cited by 269
Characterization of TMPRSS2 -ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
Mehra, R., Tomlins, S. A., Yu, J., Cao, X., Wang, L., Menon, A., Rubin, M. A., Pienta, K. J., Shah, R. B., & Chinnaiyan, A. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6154 · Cited by 269
Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention Trial
Lucia, M. S., Epstein, J. I., Goodman, P. J., Darke, A. K., Reuter, V. E., Civantos, F., Tangen, C. M., Parnes, H. L., Lippman, S. M., La Rosa, F. G., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm117 · Cited by 266
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
Sun, T., Wang, Q., Balk, S., Brown, M., Lee, G.-S. M., & Kantoff, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4112 · Cited by 263
Burger, P. E., Xiong, X., Coetzee, S., Salm, S. N., Moscatelli, D., Goto, K., & Wilson, E. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502761102 · Cited by 261
Zhu, P., Baek, S. H., Bourk, E. M., Ohgi, K. A., Garcia-Bassets, I., Sanjo, H., Akira, S., Kotol, P. F., Glass, C. K., Rosenfeld, M. G., et al. (2006) · Cell · doi:10.1016/j.cell.2005.12.032 · Cited by 259
Androgen receptor is a tumor suppressor and proliferator in prostate cancer
Niu, Y., Altuwaijri, S., Lai, K.-P., Wu, C.-T., Ricke, W. A., Messing, E. M., Yao, J., Yeh, S., & Chang, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804700105 · Cited by 256
Conditional Loss of Nkx3.1 in Adult Mice Induces Prostatic Intraepithelial Neoplasia
Abdulkadir, S. A., Magee, J. A., Peters, T. J., Kaleem, Z., Naughton, C. K., Humphrey, P. A., & Milbrandt, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1495-1503.2002 · Cited by 254
Xu, K., Shimelis, H., Linn, D. E., Jiang, R., Yang, X., Sun, F., Guo, Z., Chen, H., Li, W., Chen, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.021 · Cited by 248
Identifying Cancer Stem Cells in Solid Tumors: Case Not Proven
Hill, R. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3450 · Cited by 248
TMPRSS2 : ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
Saramäki, O. R., Harjula, A. E., Martikainen, P. M., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2051 · Cited by 243
Identification of a new prostate cancer susceptibility locus on chromosome 8q24
Yeager, M., Chatterjee, N., Ciampa, J., Jacobs, K. B., Gonzalez-Bosquet, J., Hayes, R. B., Kraft, P., Wacholder, S., Orr, N., Berndt, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.444 · Cited by 242
Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?
Attard, G., Cooper, C. S., & de Bono, J. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.11.006 · Cited by 242
Iljin, K., Wolf, M., Edgren, H., Gupta, S., Kilpinen, S., Skotheim, R. I., Peltola, M., Smit, F., Verhaegh, G., Schalken, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1986 · Cited by 241
The deficiency of Akt1 is sufficient to suppress tumor development in Pten +/− mice
Chen, M.-L., Xu, P.-Z., Peng, X., Chen, W. S., Guzman, G., Yang, X., Di Cristofano, A., Pandolfi, P. P., & Hay, N. (2006) · Genes & Development · doi:10.1101/gad.1395006 · Cited by 241
Chen, H., Tu, S.-W., & Hsieh, J.-T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501379200 · Cited by 239
Long-range enhancers on 8q24 regulate c-Myc
Sotelo, J., Esposito, D., Duhagon, M. A., Banfield, K., Mehalko, J., Liao, H., Stephens, R. M., Harris, T. J. R., Munroe, D. J., & Wu, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906067107 · Cited by 238
Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus
Jia, L., Landan, G., Pomerantz, M., Jaschek, R., Herman, P., Reich, D., Yan, C., Khalid, O., Kantoff, P., Oh, W., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000597 · Cited by 237
Diet: Fat, Meat, and Prostate Cancer
Kolonel, L. N. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000798 · Cited by 237
Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.
Kim, M., Bhatia-Gaur, R., Banach-Petrosky, W. A., et al. (2002) · PubMed · Cited by 236
Molecular signaling pathways that regulate prostate gland development
Prins, G. S., & Putz, O. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00277.x · Cited by 236
Sato, K., Qian, J., Slezak, J. M., Lieber, M. M., Bostwick, D. G., Bergstralh, E. J., & Jenkins, R. B. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1574 · Cited by 236
Yuan, T.-C., Veeramani, S., & Lin, M.-F. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-07-0061 · Cited by 231
Masumori, N., Thomas, T. Z., Chaurand, P., Case, T. C., Paul, M., Kasper, S. F., Caprioli, R. M., Tsukamoto, T., Shappell, S. B., & Matusik, R. J. (2001) · PubMed · Cited by 228
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases.
Abate-Shen, C. T., Banach-Petrosky, W. A., Sun, X., et al. (2003) · PubMed · Cited by 228
Self-citationSupplemental and Dietary Vitamin E, β-Carotene, and Vitamin C Intakes and Prostate Cancer Risk
Kirsh, V. A., Hayes, R. B., Mayne, S. T., Chatterjee, N., Subar, A. F., Dixon, L. B., Albanes, D., Andriole, G. L., Urban, D. A., & Peters, U. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj050 · Cited by 226
Sfanos, K. S., Sauvageot, J., Fedor, H. L., Dick, J. D., De Marzo, A. M., & Isaacs, W. B. (2008) · The Prostate · doi:10.1002/pros.20680 · Cited by 219
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors
Dong, B., Kim, S., Hong, S., Das Gupta, J., Malathi, K., Klein, E. A., Ganem, D., DeRisi, J. L., Chow, S. A., & Silverman, R. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610291104 · Cited by 219
Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
Wang, S. I., Parsons, R. E., & Ittmann, M. (1998) · PubMed · Cited by 218
Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate
Wang, L., Liu, R., Li, W., Chen, C., Katoh, H., Chen, G.-Y., McNally, B., Lin, L., Zhou, P., Zuo, T., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.016 · Cited by 218
Prostate Development Requires Sonic Hedgehog Expressed by the Urogenital Sinus Epithelium
Podlasek, C. A., Barnett, D. H., Clemens, J. Q., Bak, P. M., & Bushman, W. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9229 · Cited by 218
Dunn, J. E. (1975) · PubMed · Cited by 217
PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer
Mulholland, D. J., Dedhar, S., Wu, H., & Nelson, C. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209020 · Cited by 216
Abreu-Martin, M. T., Chari, A., Palladino, A. A., Craft, N. A., & Sawyers, C. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5143 · Cited by 216
Mosquera, J.-M., Perner, S., Genega, E. M., Sanda, M., Hofer, M. D., Mertz, K. D., Paris, P. L., Simko, J., Bismar, T. A., Ayala, G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5194 · Cited by 215
Mehra, R., Han, B., Tomlins, S. A., Wang, L., Menon, A., Wasco, M. J., Shen, R., Montie, J. E., Chinnaiyan, A. M., & Shah, R. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2043 · Cited by 214
Kelley, M. R., Cheng, L., Foster, R. S., Tritt, R., Jiang, J., Broshears, J. R., & Koch, M. O. (2001) · PubMed · Cited by 214
Birnie, R., Bryce, S. D., Roome, C., Dussupt, V., Droop, A., Lang, S. H., Berry, P. A., Hyde, C. F., Lewis, J. L., Stower, M. J., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-5-r83 · Cited by 212
Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes
Attar, R. M., Takimoto, C. H., & Gottardis, M. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1171 · Cited by 212
Wu, C.-T., Altuwaijri, S., Ricke, W. A., Huang, S.-P., Yeh, S., Zhang, C., Niu, Y., Tsai, M.-Y., & Chang, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704940104 · Cited by 211
Steinkamp, M. P., O'Mahony, O. A., Brogley, M., Rehman, H., LaPensee, E. W., Dhanasekaran, S., Hofer, M. D., Kuefer, R., Chinnaiyan, A., Rubin, M. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3605 · Cited by 210
Sircar, K., Yoshimoto, M., Monzon, F. A., Koumakpayi, I. H., Katz, R. L., Khanna, A., Alvarez, K., Chen, G., Darnel, A. D., Aprikian, A. G., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2559 · Cited by 208
Cancer Stem Cells: An Old Idea--A Paradigm Shift
Wicha, M. S., Liu, S., & Dontu, G. (2008) · AACR Education book · doi:10.1158/aacr.edb-can-05-3153 · Cited by 207
Human prostate cancer precursors and pathobiology
De Marzo, A. M., Meeker, A. K., Zha, S., Luo, J., Nakayama, M., Platz, E. A., Isaacs, W. B., & Nelson, W. G. (2003) · Urology · doi:10.1016/j.urology.2003.09.053 · Cited by 204
Role of p63 and basal cells in the prostate
Kurita, T., Medina, R. T., Mills, A. A., & Cunha, G. R. (2004) · Development · doi:10.1242/dev.01384 · Cited by 204
Is Tumor Growth Sustained by Rare Cancer Stem Cells or Dominant Clones?
Adams, J. M., & Strasser, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6334 · Cited by 204
Zong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203
Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system
Kurita, T., Wang, Y. Z., Donjacour, A. A., Zhao, C., Lydon, J. P., O'Malley, B. W., Isaacs, J. T., Dahiya, R., & Cunha, G. R. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400797 · Cited by 203
Role of SRC-1 in the Promotion of Prostate Cancer Cell Growth and Tumor Progression
Agoulnik, I. U., Vaid, A., Bingman, W. E., Erdeme, H., Frolov, A., Smith, C. L., Ayala, G., Ittmann, M. M., & Weigel, N. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3541 · Cited by 202
Memarzadeh, S., Xin, L., Mulholland, D. J., Mansukhani, A., Wu, H., Teitell, M. A., & Witte, O. N. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.002 · Cited by 201
Bostwick, D. G., Shan, A., Qian, J., Darson, M. F., Maihle, N. J., Jenkins, R. B., & Liang Cheng, C. (1998) · Cancer · Cited by 199
Lei, Q., Jiao, J., Xin, L., Chang, C.-J., Wang, S., Gao, J., Gleave, M. E., Witte, O. N., Liu, X., & Wu, H. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.031 · Cited by 198
GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer
Nakayama, M., Gonzalgo, M. L., Yegnasubramanian, S., Lin, X., De Marzo, A. M., & Nelson, W. G. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10740 · Cited by 197
Xin, L., Ide, H., Kim, Y., Dubey, P., & Witte, O. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734139100 · Cited by 195
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation
Gao, N., Ishii, K., Mirosevich, J., Kuwajima, S., Oppenheimer, S. R., Roberts, R. L., Jiang, M., Yu, X., Shappell, S. B., Caprioli, R. M., et al. (2005) · Development · doi:10.1242/dev.01917 · Cited by 193
Chromosomal Deletions and Tumor Suppressor Genes in Prostate Cancer
Dong, J.-T. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015575125780 · Cited by 192
Mutation of the androgen receptor causes oncogenic transformation of the prostate.
Han, G., Buchanan, G., Ittmann, M., Harris, J. M., Yu, X., DeMayo, F. J., Tilley, W., & Greenberg, N. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408925102 · Cited by 192
The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis
Frohlich, D. A., McCabe, M. T., Arnold, R. S., & Day, M. L. (2008) · Oncogene · doi:10.1038/onc.2008.79 · Cited by 192
Corey, E., Quinn, J. E., Bladou, F., Brown, L. G., Roudier, M. P., Brown, J. M., Buhler, K. R., & Vessella, R. L. (2002) · The Prostate · doi:10.1002/pros.10091 · Cited by 192
NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth
Zhang, L., Altuwaijri, S., Deng, F., Chen, L., Lal, P., Bhanot, U. K., Korets, R., Wenske, S., Lilja, H. G., Chang, C., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080727 · Cited by 191
Ma, X., Ziel-van der Made, A. C., Autar, B., van der Korput, H. A., Vermeij, M., van Duijn, P., Cleutjens, K. B., de Krijger, R., Krimpenfort, P., Berns, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4519 · Cited by 191
Will mTOR inhibitors make it as cancer drugs?
Sawyers, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00275-7 · Cited by 190
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Leversha, M. A., Han, J., Asgari, Z., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Anand, A., Lilja, H., Heller, G., Fleisher, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2036 · Cited by 188
Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis
Ouyang, X., DeWeese, T. L., Nelson, W. G., & Abate-Shen, C. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1948 · Cited by 186
Self-citationThe role of Src in prostate cancer
Fizazi, K. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm086 · Cited by 183
Precise microdissection of human prostate cancers reveals genotypic heterogeneity.
Macintosh, C. A., Stower, M. J., Reid, N., & Maitland, N. J. (1998) · PubMed · Cited by 181
Stem cells in prostate cancer initiation and progression
Lawson, D. A., & Witte, O. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32810 · Cited by 179
Mulholland, D. J., Xin, L., Morim, A., Lawson, D., Witte, O., & Wu, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4673 · Cited by 179
Gao, J., Arnold, J. T., & Isaacs, J. T. (2001) · PubMed · Cited by 175
Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
Wang, J., Cai, Y., Yu, W., Ren, C., Spencer, D. M., & Ittmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1147 · Cited by 173
Choi, J., Shendrik, I., Peacocke, M., Peehl, D., Buttyan, R., Ikeguchi, E. F., Katz, A. E., & Benson, M. C. (2000) · Urology · doi:10.1016/s0090-4295(00)00538-0 · Cited by 173
Coppola, V., Maria, R. D., & Bonci, D. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0172 · Cited by 173
Primary cell cultures as models of prostate cancer development
Peehl, D. M. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00795 · Cited by 173
Schaeffer, E. M., Marchionni, L., Huang, Z., Simons, B., Blackman, A., Yu, W., Parmigiani, G., & Berman, D. M. (2008) · Oncogene · doi:10.1038/onc.2008.327 · Cited by 172
Jiao, J., Wang, S., Qiao, R., Vivanco, I., Watson, P. A., Sawyers, C. L., & Wu, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4202 · Cited by 172
Evans, G. S., & Chandler, J. A. (1987) · The Prostate · doi:10.1002/pros.2990110406 · Cited by 171
FGF-10 plays an essential role in the growth of the fetal prostate
Donjacour, A. A., Thomson, A. A., & Cunha, G. R. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00250-1 · Cited by 170
Stanbrough, M., Leav, I., Kwan, P. W. L., Bubley, G. J., & Balk, S. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191235898 · Cited by 169
Cellular senescence and chromatin structure
Funayama, R., & Ishikawa, F. (2007) · Chromosoma · doi:10.1007/s00412-007-0115-7 · Cited by 169
Crosstalk between the Androgen Receptor and β-Catenin in Castrate-Resistant Prostate Cancer
Wang, G., Wang, J., & Sadar, M. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1718 · Cited by 168
Attard, G., Reid, A. H. M., Olmos, D., & de Bono, J. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4531 · Cited by 168
Xiang, Y., Wang, Z., Murakami, J., Plummer, S. J., Klein, E. A., Carpten, J. D., Trent, J. M., Isaacs, W. B., Casey, G., & Silverman, R. H. (2003) · PubMed · Cited by 167
Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer
Dakhova, O., Ozen, M., Creighton, C. J., Li, R., Ayala, G., Rowley, D., & Ittmann, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1899 · Cited by 166
CELL LINES USED IN PROSTATE CANCER RESEARCH: A COMPENDIUM OF OLD AND NEW LINES—PART 2
SOBEL, R. E., & SADAR, M. D. (2005) · Journal of Urology · doi:10.1097/01.ju.0000149989.01263.dc · Cited by 166
Unusual subtypes of prostate cancer
Grignon, D. J. (2004) · Modern Pathology · doi:10.1038/modpathol.3800052 · Cited by 165
Sonic Hedgehog Activates Mesenchymal Gli1 Expression during Prostate Ductal Bud Formation
Lamm, M. L. G., Catbagan, W. S., Laciak, R. J., Barnett, D. H., Hebner, C. M., Gaffield, W., Walterhouse, D., Iannaccone, P., & Bushman, W. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0774 · Cited by 165
Ke, X.-S., Qu, Y., Rostad, K., Li, W.-C., Lin, B., Halvorsen, O. J., Haukaas, S. A., Jonassen, I., Petersen, K., Goldfinger, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004687 · Cited by 164
Capasso, L. L. (2005) · International Journal of Cancer · doi:10.1002/ijc.20610 · Cited by 161
Oxidative stress-related aging: A role for prostate cancer?
Minelli, A., Bellezza, I., Conte, C., & Čulig, Z. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.11.001 · Cited by 159
Watson, P. A., Ellwood-Yen, K., King, J. C., Wongvipat, J., LeBeau, M. M., & Sawyers, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3441 · Cited by 159
Xin, L., Teitell, M. A., Lawson, D. A., Kwon, A., Mellinghoff, I. K., & Witte, O. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602567103 · Cited by 158
Cellular senescence in the pathogenesis of benign prostatic hyperplasia
Castro, P. D., Giri, D., Lamb, D. J., & Ittmann, M. (2003) · The Prostate · doi:10.1002/pros.10204 · Cited by 157
Complex patterns of ETS gene alteration arise during cancer development in the human prostate
Clark, J., Attard, G., Jhavar, S. G., Flohr, P., Reid, A. H. M., Bono, J. S. D., Eeles, R. A., Scardino, P. T., Cuzick, J. M., Fisher, G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210843 · Cited by 156
Deletion, Methylation, and Expression of the NKX3.1 Suppressor Gene in Primary Human Prostate Cancer
Asatiani, E., Huang, W.-X., Wang, A., Ortner, E., Cavalli, L. R., Haddad, B. R., & Gelmann, E. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2688 · Cited by 156
Ellis, W. J., Vessella, R. L., Buhler, K. R., Bladou, F., True, L. D., Bigler, S. A., Curtis, D., & Lange, P. H. (1996) · PubMed · Cited by 153
Mesenchymal–epithelial interactions: past, present, and future
Cunha, G. R. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00290.x · Cited by 151
Diagnosis of adenocarcinoma in prostate needle biopsy tissue
Humphrey, P. A. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.036442 · Cited by 150
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages
Niu, Y., Altuwaijri, S., Yeh, S., Lai, K., Yu, S., Chuang, K., Huang, S., Lardy, H. A., & Chang, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804701105 · Cited by 149
Minireview: Epigenetic Alterations in Human Prostate Cancers
Nelson, W. G., Marzo, A. M. D., & Yegnasubramanian, S. (2009) · Endocrinology · doi:10.1210/en.2009-0573 · Cited by 149
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
Wang, J., Kim, J., Roh, M., Franco, O. E., Hayward, S. W., Wills, M. L., & Abdulkadir, S. A. (2010) · Oncogene · doi:10.1038/onc.2010.10 · Cited by 149
Sonic hedgehog regulates prostatic growth and epithelial differentiation
Freestone, S. H., Marker, P. C., Grace, O. C., Tomlinson, D. C., Cunha, G. R., Harnden, P., & Thomson, A. A. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.08.018 · Cited by 148
Saramäki, O. R., Tammela, T. L. J., MARTIKAINEN, P. M., Vessella, R. L., & Visakorpi, T. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20327 · Cited by 146
Abate-Shen, C. T., Shen, M. M., & Gelmann, E. P. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00292.x · Cited by 144
Self-citationPten Inactivation and the Emergence of Androgen-Independent Prostate Cancer
Shen, M. M., & Abate-Shen, C. T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1271 · Cited by 144
Self-citationKunderfranco, P., Mello-Grand, M., Cangemi, R., Pellini, S., Mensah, A., Albertini, V., Malek, A., Chiorino, G., Catapano, C. V., & Carbone, G. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010547 · Cited by 143
Haploinsufficiency at the Nkx3.1 locus
Magee, J. A., Abdulkadir, S. A., & Milbrandt, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00047-3 · Cited by 143
Gao, H., Ouyang, X., Banach-Petrosky, W. A., Gerald, W. L., Shen, M. M., & Abate-Shen, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606836103 · Cited by 141
Self-citationNeuroendocrine differentiation in the progression of prostate cancer
Komiya, A., Suzuki, H., Imamoto, T., Kamiya, N., Nihei, N., Naya, Y., Ichikawa, T., & Fuse, H. (2008) · International Journal of Urology · doi:10.1111/j.1442-2042.2008.02175.x · Cited by 140
Cellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 140
Abnormal DNA methylation, epigenetics, and prostate cancer
William, G. N. (2007) · Frontiers in bioscience · doi:10.2741/2385 · Cited by 138
Urine biomarkers in prostate cancer
Ploussard, G., & TAILLE, A. D. L. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2009.261 · Cited by 137
Iwata, T., Schultz, D., Hicks, J. L., Hubbard, G. K., Mutton, L. N., Lotan, T. L., Bethel, C. R., Lotz, M. T., Yegnasubramanian, S., Nelson, W. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009427 · Cited by 137
Prostate development: a historical perspective
Timms, B. G. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00278.x · Cited by 137
Roles for Hedgehog signaling in androgen production and prostate ductal morphogenesis
Berman, D. M., Desai, N., Wang, X., Karhadkar, S. S., Reynon, M., Abate-Shen, C. T., Beachy, P. A., & Shen, M. M. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2003.11.018 · Cited by 135
Self-citationCholesterol Sensitivity of Endogenous and Myristoylated Akt
Adam, R. M., Mukhopadhyay, N. K., Kim, J., Vizio, D. D., Cinar, B., Boucher, K., Solomon, K. R., & Freeman, M. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0288 · Cited by 134
Lin, H., Hu, Y., Lee, D., & Chang, C. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0117 · Cited by 134
Expression Signature of the Mouse Prostate
Berquin, I. M., Min, Y.-N., Wu, R., Wu, H., & Chen, Y. Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504945200 · Cited by 131
Fradet, V., Lessard, L., Bégin, L. R., Karakiewicz, P. I., Mes‐Masson, A., & Fred Saad, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0764 · Cited by 131
Morphological features of TMPRSS2–ERG gene fusion prostate cancer
Mosquera, J. M., Perner, S., Demichelis, F., Kim, R., Hofer, M. D., Mertz, K. D., Paris, P., Simko, J., Collins, C. C., Bismar, T., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2154 · Cited by 129
Begley, L., Monteleon, C. L., Shah, R. B., MacDonald, J. W., & Macoska, J. A. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00173.x · Cited by 128
Signal transduction in prostate cancer progression
Gioeli, D. G. (2005) · Clinical Science · doi:10.1042/cs20040329 · Cited by 127
Schmitz, M., Grignard, G., Margue, C., Dippel, W., Capesius, C., Mossong, J., Nathan, M., Giacchi, S., Scheiden, R., & Kieffer, N. (2006) · International Journal of Cancer · doi:10.1002/ijc.22359 · Cited by 126
Evaluating Localized Prostate Cancer and Identifying Candidates for Focal Therapy
Sartor, O. A., Hricak, H., Wheeler, T. M., Coleman, J., Penson, D. F., Carroll, P. R., Rubin, M. A., & Scardino, P. T. (2008) · Urology · doi:10.1016/j.urology.2008.10.004 · Cited by 124
Inflammation, atrophy, and prostate carcinogenesis
Marzo, A. M. D., Nakai, Y., & Nelson, W. G. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.05.007 · Cited by 123
Song, H., Zhang, B., Watson, M. A., Humphrey, P. A., Lim, H. J., & Milbrandt, J. (2009) · Oncogene · doi:10.1038/onc.2009.181 · Cited by 123
A critical role for p27 kip1 gene dosage in a mouse model of prostate carcinogenesis
Gao, H., Ouyang, X., Banach-Petrosky, W. A., Borowsky, A. D., Lin, Y., Kim, M., Lee, H., Shih, W. J., Cardiff, R. D., Shen, M. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407693101 · Cited by 123
Self-citationYu, X., Wang, Y., Jiang, M., Bierie, B., Roy‐Burman, P., Shen, M. M., Taketo, M. M., Wills, M. L., & Matusik, R. J. (2008) · The Prostate · doi:10.1002/pros.20877 · Cited by 121
Self-citationUzgare, A. R., & Isaacs, J. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0968 · Cited by 121
Cancer stem cells: a model in the making
Marotta, L. L. C., & Polyák, K. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.12.003 · Cited by 119
Kraus, S., Gioeli, D., Vomastek, T., Gordon, V., & Weber, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0596 · Cited by 118
Ma, L., Teruya‐Feldstein, J., Behrendt, N., Chen, Z., Noda, T., Hino, O., Cordon‐Cardo, C., & Pandolfi, P. P. (2005) · Genes & Development · doi:10.1101/gad.1314405 · Cited by 115
Inflammation, infection, and prostate cancer
Klein, E. A., & Silverman, R. H. (2008) · Current Opinion in Urology · doi:10.1097/mou.0b013e3282f9b3b7 · Cited by 111
Evaluation of the 8q24 Prostate Cancer Risk Locus and MYC Expression
Pomerantz, M. M., Beckwith, C. A., Regan, M. M., Wyman, S. K., Petrovics, G., Chen, Y., Hawksworth, D. J., Schumacher, F. R., Mucci, L. A., Penney, K. L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0387 · Cited by 111
Xu, J., Zheng, S. L., Carpten, J. D., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/319513 · Cited by 110
Schneider, A., Brand, T., Zweigerdt, R., & Arnold, H.-H. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00355-5 · Cited by 110
Inactivation of Apc in the Mouse Prostate Causes Prostate Carcinoma
Bruxvoort, K. J., Charbonneau, H. M., Giambernardi, T. A., Goolsby, J. C., Qian, C.-N., Diegel, C. R., Robinson, D. R., Roy‐Burman, P., Shaw, A. K., Buckner-Berghuis, B. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3028 · Cited by 108
Ratnacaram, C. K., Teletin, M., Jiang, M., Meng, X., Chambon, P., & METZGER, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712021105 · Cited by 108
Verhagen, P. C. M. S., van Duijn, P. W., Hermans, K., Looijenga, L. H. J., van Gurp, R., Stoop, H., van der Kwast, T., & Trapman, J. (2006) · The Journal of Pathology · doi:10.1002/path.1929 · Cited by 108
Improved prediction of prostate cancer recurrence through systems pathology
Cordon‐Cardo, C., Kotsianti, A., Verbel, D., Teverovskiy, M., Capodieci, P., Hamann, S., Jeffers, Y., Clayton, M., Elkhettabi, F., Khan, F. M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31399 · Cited by 108
Elkahwaji, J. E., Zhong, W., Hopkins, W. J., & BUSHMAN, W. A. (2006) · The Prostate · doi:10.1002/pros.20445 · Cited by 107
(2001) · PubMed · Cited by 106
Lin, Y., Liu, G., Zhang, Y., Hu, Y.-P., Yu, K., Lin, C., McKeehan, K. A., Xuan, J. W., Ornitz, D. M., Shen, M. M., et al. (2007) · Development · doi:10.1242/dev.02765 · Cited by 106
Self-citationKader, A. K., Sun, J., Isaacs, S. D., Wiley, K. E., Yan, G., Kim, S., Fedor, H. L., Marzo, A. M. D., Epstein, J. I., Walsh, P. C., et al. (2009) · The Prostate · doi:10.1002/pros.20970 · Cited by 106
Nakai, Y., Nelson, W. G., & Marzo, A. M. D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1336 · Cited by 106
Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.
Wang, Y. Z., Hayward, S. W., Donjacour, A. A., Young, P., Jacks, T., Sage, J., Dahiya, R., Cardiff, R. D., Day, M. L., & Cunha, G. R. (2000) · PubMed · Cited by 106
Immortalization of primary human prostate epithelial cells by c-Myc
Gil, J., Kerai, P., Lleonart, M., Bernard, D., Cigudosa, J. C., Peters, G., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-4030 · Cited by 105
Sox9 is required for prostate development
Thomsen, M. K., Butler, C. M., Shen, M. M., & Swain, A. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.01.030 · Cited by 100
Self-citationDelineation of TMPRSS2-ERG Splice Variants in Prostate Cancer
Hu, Y., Dobi, A., Sreenath, T., Cook, C., Tadase, A. Y., Ravindranath, L., Cullen, J. C., Furusato, B., Chen, Y., Thangapazham, R. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0531 · Cited by 99
NKX3.1 Activates Cellular Response to DNA Damage
Bowen, C., & Gelmann, E. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3138 · Cited by 98
Expression of NF‐κB in prostate cancer lymph node metastases
A, H. I., Lessard, L., Mes‐Masson, A., & Fred Saad, C. (2003) · The Prostate · doi:10.1002/pros.10335 · Cited by 97
Prostate inflammation and its potential impact on prostate cancer: A current review
Haverkamp, J. M., Charbonneau, B., & Ratliff, T. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21536 · Cited by 96
The role of Wnt5a in prostate gland development
Huang, L., Pu, Y., Hu, W., Birch, L. A., Luccio-Camelo, D., Yamaguchi, T. P., & Prins, G. S. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.01.003 · Cited by 96
K-ras and Wnt Signaling Synergize to Accelerate Prostate Tumorigenesis in the Mouse
Pearson, H. B., Phesse, T. J., & Clarke, A. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2895 · Cited by 94
Vukovic, B., Park, P. C., Al-Maghrabi, J. A., Beheshti, B., Sweet, J., Evans, A., Trachtenberg, J., & Squire, J. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206227 · Cited by 94
Vitamin D Inhibits the Formation of Prostatic Intraepithelial Neoplasia in Nkx3.1; Pten Mutant Mice
Banach-Petrosky, W. A., Ouyang, X., Gao, H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1039 · Cited by 93
Genetic Analysis of the RNASEL Gene in Hereditary, Familial, and Sporadic Prostate Cancer
Wiklund, F. E., Jonsson, B., Brookes, A. J., Strömqvist, L., Adolfsson, J., Emanuelsson, M., Adami, H., Bälter, K. A., & Grönberg, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0982 · Cited by 93
p63 in prostate biology and pathology
Grisanzio, C., & Signoretti, S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21555 · Cited by 93
Freeman, K. W., Gangula, R., Welm, B. E., Özen, M., Foster, B. A., Rosen, J. M., Ittmann, M., Greenberg, N. M., & Spencer, D. M. (2003) · PubMed · Cited by 92
Berruti, A., Mosca, A., Porpiglia, F., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.05.018 · Cited by 91
MicroRNAs and their potential for translation in prostate cancer
White, R. D., Vinall, R. L., Tepper, C. G., & Shi, X.-B. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.01.004 · Cited by 91
Epithelial stem cells in human prostate growth and disease
Hudson, D. L. (2004) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500745 · Cited by 89
Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer
Kim, J., Eltoum, I., Roh, M., Wang, J., & Abdulkadir, S. A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000542 · Cited by 88
Gao, H., Ouyang, X., Banach-Petrosky, W. A., Shen, M. M., & Abate-Shen, C. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1637 · Cited by 87
Self-citationLessard, L., Karakiewicz, P. I., Bellon-Gagnon, P., Alam‐Fahmy, M., Ismail, H. A., Mes‐Masson, A., & Fred Saad, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0330 · Cited by 87
Korsten, H., der Made, A. Z., Ma, X., van der Kwast, T., & Trapman, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005662 · Cited by 86
Pleiotropic functional properties of androgen receptor mutants in prostate cancer
Bergerat, J., & Céraline, J. (2008) · Human Mutation · doi:10.1002/humu.20848 · Cited by 86
TELOMERASE ACTIVITY, TELOMERE LENGTH, AND DNA PLOIDY IN PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN)
Koeneman, K. S., Pan, C.-X., JIN, J.-K., Pyle, J. M., Flanigan, R. C., Shankey, T. V., & Dı́az, M. O. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62608-9 · Cited by 84
Functional compensation in Hedgehog signaling during mouse prostate development
Doles, J. D., Cook, C. H., Shi, X., Valosky, J., Lipinski, R. J., & BUSHMAN, W. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.12.002 · Cited by 82
Loss of PTEN is associated with progression to androgen independence
Bertram, J., Peacock, J. W., Fazli, L., Mui, A., Chung, S. W., Cox, M., Monia, B. P., Gleave, M. E., & Ong, C. J. (2006) · The Prostate · doi:10.1002/pros.20411 · Cited by 81
Banach-Petrosky, W. A., Jessen, W. J., Ouyang, X., Gao, H., Rao, J., Quinn, J., Aronow, B. J., & Abate-Shen, C. T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2887 · Cited by 81
Self-citationKobayashi, N., Barnard, R. J., SAID, J. W., Hong-Gonzalez, J., Corman, D. M., Ku, M., Doan, N., Gui, D., Elashoff, D. A., Cohen, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5616 · Cited by 81
Song, Z., Wu, X., Powell, W. C., Cardiff, R. D., Cohen, M. B., Tin, R. T., Matusik, R. J., Miller, G. J., & Roy‐Burman, P. (2002) · PubMed · Cited by 81
van Leenders, G. J. L. H., & Schalken, J. A. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00059-3 · Cited by 80
The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome
Silverman, R. H., Nguyen, C. T., Weight, C., & Klein, E. A. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.77 · Cited by 80
ASSOCIATION BETWEEN CANCER-FREE SURVIVAL AND TELOMERE DNA CONTENT IN PROSTATE TUMORS
Fordyce, C., Heaphy, C. M., Joste, N. E., Smith, A. Y., Hunt, W. C., & Griffith, J. K. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000143195.49685.ce · Cited by 80
Brooke, G. N., Parker, M. G., & Bevan, C. L. (2008) · Oncogene · doi:10.1038/sj.onc.1210955 · Cited by 79 · cited 1×
“…increased protein stability, greater sensitivity to androgens, novel responses to other steroid hormones, ligand-independent activity, or increased recruitment of AR coactivator proteins (Taplin et al. 1995, 2003; Zhao et al. 2000; Robzyk et al. 2007; Brooke et al. 2008; Steinkamp et al. 2009).”
BackgroundProstate cancer prevention: Past, present, and future
Fleshner, N. E., & Zlotta, A. R. (2007) · Cancer · doi:10.1002/cncr.23009 · Cited by 79
From pathogenesis to prevention of castration resistant prostate cancer
Bonkhoff, H., & Berges, R. R. (2009) · The Prostate · doi:10.1002/pros.21042 · Cited by 79
Current Indications for Chemotherapy in Prostate Cancer Patients
Calabrò, F., & Sternberg, C. N. (2006) · European Urology · doi:10.1016/j.eururo.2006.08.013 · Cited by 78
IN VIVO MODELS OF PROSTATE CANCER METASTASIS TO BONE
Singh, A. S., & Figg, W. D. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000169133.82167.aa · Cited by 78
Conserved Gene Expression Programs Integrate Mammalian Prostate Development and Tumorigenesis
Pritchard, C. C., Mecham, B., Dumpit, R. F., Coleman, I. M., Bhattacharjee, M., Chen, Q., Sikes, R. A., & Nelson, P. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-6817 · Cited by 78
Shaw, A. K., Gipp, J. J., & BUSHMAN, W. A. (2009) · Nature Precedings · doi:10.1038/onc.2009.294 · Cited by 78
Antibody-Based Profiling of the Phosphoinositide 3-Kinase Pathway in Clinical Prostate Cancer
THOMAS, G. V., Horvath, S., Smith, B. L., Crosby, K., Lebel, L. A., Schrage, M. I., Said, J. W., Kernion, J. D., Reiter, R. E., & Sawyers, C. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0130 · Cited by 76
Liao, C., Zhong, C., Saribekyan, G., Bading, J. R., Park, R., Conti, P. S., Moats, R. A., Berns, A. J. M., Shi, W., Zhou, Z., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0668 · Cited by 75
Kasper, S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20339 · Cited by 75
Differential p53-Independent Outcomes of p19 Arf Loss in Oncogenesis
Chen, Z., Carracedo, A., Lin, H., Koutcher, J. A., Behrendt, N., Egia, A., Alimonti, A., Carver, B. S., Gerald, W. L., Teruya‐Feldstein, J., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000053 · Cited by 74
Anti-inflammatory drugs, antioxidants, and prostate cancer prevention
Bardia, A., Platz, E. A., Yegnasubramanian, S., Marzo, A. M. D., & Nelson, W. G. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.002 · Cited by 73
Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression
Zhang, Z., Rosen, D. G., Yao, J. L., Huang, J., & Liu, J. (2006) · Modern Pathology · doi:10.1038/modpathol.3800655 · Cited by 73
Markowski, M. C., Bowen, C., & Gelmann, E. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0578 · Cited by 72
Chen, Z., Koeneman, K. S., & Corey, D. R. (2003) · PubMed · Cited by 72
Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans
Hooker, S. E., Hernandez, W., Chen, H., Robbins, C. M., Torres, J. B., Ahaghotu, C. A., Carpten, J. D., & Kittles, R. A. (2009) · The Prostate · doi:10.1002/pros.21061 · Cited by 72
Alterations in β‐catenin expression and localization in prostate cancer
Whitaker, H. C., Girling, J., Warren, A. Y., Leung, H. Y., Mills, I. G., & Neal, D. E. (2008) · The Prostate · doi:10.1002/pros.20780 · Cited by 71
Jiang, M., Strand, D. W., Fernandez, S., He, Y., Yi, Y., Birbach, A., Qiu, Q., Schmid, J. A., Tang, D. G., & Hayward, S. W. (2009) · Stem Cells · doi:10.1002/stem.284 · Cited by 70
Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate
Elkahwaji, J. E., Hauke, R. J., & Brawner, C. M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605370 · Cited by 70
Hill, R., Song, Y., Cardiff, R. D., & Dyke, T. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1579 · Cited by 69
Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer
Horvath, L. G., Henshall, S. M., Lee, C. S., Kench, J. G., Golovsky, D., Brenner, P. C., O’Neill, G., Kooner, R., Stricker, P. D., Grygiel, J. J., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20599 · Cited by 67
Cited by
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Punctuated Evolution of Prostate Cancer Genomes
Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T. Y., Ghandi, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.021 · Cited by 1,320
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., & Mashele, S. (2022) · Molecules · doi:10.3390/molecules27175730 · Cited by 904
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Metadata
- Authors
- Shen, M. M., & Abate-Shen, C.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-09-15
- Volume
- 24
- Issue
- 18
- Pages
- 1967-2000
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2148416479
- Cited by
- 946
- References
- 428
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.